About Cordlife
Cordlife is a company based in Singapore (Singapore) founded in 2001. It operates as a Subscription Services and Professional Services. Cordlife has raised $7 million across 1 funding round from investors including Rothschild, APC Investors and UOB Venture Management. Cordlife has completed 1 acquisition, including StemLife. Cordlife offers products and services including Cord Blood Banking, Cord Lining Banking, Cord Tissue Banking, Non-Invasive Prenatal Testing, and Newborn Metabolic Screening. Cordlife operates in a competitive market with competitors including LifeCell, ViaCord, Calmark, Esperite and Cordlife India, among others.
- Headquarter Singapore, Singapore
- Stage Public
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Cordlife Group Limited
-
Annual Revenue
$20.28 M (USD)-50.39as on Dec 31, 2024
-
Net Profit
-$13.85 M (USD)-635.99as on Dec 31, 2024
-
EBITDA
-$14.81 M (USD)-765.24as on Dec 31, 2024
-
Total Equity Funding
$7 M (USD)
in 1 rounds
-
Latest Funding Round
$7 M (USD), Series B
Nov 04, 2003
-
Investors
Rothschild
& 2 more
-
Employee Count
Not available
- Investments & Acquisitions
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of Cordlife
Cordlife is a publicly listed company on the SGX with ticker symbol P8A in Singapore, operating in the Health services sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Products & Services of Cordlife
Cordlife offers a comprehensive portfolio of products and services, including Cord Blood Banking, Cord Lining Banking, Cord Tissue Banking, Non-Invasive Prenatal Testing, and Newborn Metabolic Screening.
Cord blood is stored for future medical use.
Cord lining is preserved for potential therapeutic applications.
Cord tissue is banked for future regenerative treatments.
Prenatal testing is offered for early health insights.
Metabolic screening is provided for newborn health checks.
People of Cordlife
Unlock access to complete
Unlock access to complete
Funding Insights of Cordlife
Cordlife has successfully raised a total of $7M through 1 strategic funding round. The most recent funding activity was a Series B round of $7 million completed in November 2003. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Cordlife
Cordlife has secured backing from 3 investors, including institutional and venture fund investors. Prominent investors backing the company include Rothschild, APC Investors and UOB Venture Management.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Limited information is provided about UOB Venture Management.
|
Locked | Locked | Locked | |
|
Manages diversified investment portfolios across multiple asset classes for clients.
|
Locked | Locked | Locked | |
|
Global investment banking services are provided worldwide.
|
Locked | Locked | Locked |
Investor details for Cordlife
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Cordlife
Cordlife has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include StemLife.
Investment portfolio details for Cordlife
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Cord blood and tissue banking, plus genetic testing, is provided.
|
Locked | Locked | 2001 | Locked |
Complete acquisition details for Cordlife
Transaction dates, acquired stakes, disclosed values, domains, and locations require an active premium plan.
- Transaction dates
- Acquired stakes
- Disclosed values
- Domains and locations
Verified entity values are shown only after access is granted.
Financial Statements - Cordlife
Detailed financials for Cordlife
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Cordlife Comparisons
Peer comparison for Cordlife
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Cordlife
Cordlife operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as LifeCell, ViaCord, Calmark, Esperite and Cordlife India, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
LifeCell is engaged in cord blood banking services.
|
|
| Locked | Locked | Locked |
Provider of services for cord blood and stem cell banking
|
|
| Locked | Locked | Locked |
Point-of-care diagnostics for neonatal care are developed.
|
|
| Locked | Locked | Locked |
Umbilical cord blood stem cells are collected, processed, and stored.
|
|
| Locked | Locked | Locked |
Offers stem cell banking services for cord blood and cord lining storage globally.
|
Detailed competitors of Cordlife
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Cordlife
Complete news archive for Cordlife
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Cordlife
Cordlife was founded in 2001 and raised its 1st funding round 2 years after it was founded.
Cordlife is headquartered in Singapore, Singapore.
Cordlife is a funded company, having raised a total of $7M across 1 funding round to date.
Annual revenue of Cordlife is $20.28M as on Dec 31, 2024.
Cordlife Group Limited is focused on safeguarding the well-being of mother and child through private cord blood banking and related healthcare services. Operating primarily in Asia, the company is recognized as a pioneer in stem cell banking with facilities in Singapore, Hong Kong, Indonesia, the Philippines, India, and Malaysia. A comprehensive suite of diagnostics services, including non-invasive prenatal testing and newborn metabolic screening, is provided alongside cord blood, lining, and tissue banking. Innovation and technological advancement are emphasized to ensure reliable healthcare solutions across its markets.
Cordlife offers Cord Blood Banking, Cord Lining Banking, Cord Tissue Banking, Non-Invasive Prenatal Testing, and Newborn Metabolic Screening.
Yes, Cordlife is publicly traded on SGX under the ticker symbol P8A.
Cordlife has made 1 acquisition, including StemLife.
Cordlife has 3 investors. Key investors include Rothschild, APC Investors, and UOB Venture Management.
The ticker symbol of Cordlife is P8A on SGX.